Hurco Cos Inc (HURC) 31.68 $HURC Hurco Companies, Inc.

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Hurco Cos Inc (HURC) 31.68 $HURC

Hurco Companies, Inc. Announces Quarterly Cash Dividend
GlobeNewswire - 1 hr 17 mins ago
Hurco Companies, Inc. (Nasdaq:HURC), an international industrial technology company, announced today that its Board of Directors approved the payment of a cash dividend of $0.09 per share. The dividend will be paid on July 11, 2016, to shareholders of record as of the close of business on June 27, 2016.
HURC: 31.68 (-0.45)

Hurco Reports Fiscal 2016 Second Quarter Results
GlobeNewswire - Fri Jun 03, 7:00AM CDT
Hurco Companies, Inc. (Nasdaq:HURC) today reported results for the second fiscal quarter ended April 30, 2016. Hurco recorded net income of $3,674,000, or $0.56 per diluted share, for the second quarter of fiscal 2016 compared to net income of $3,961,000, or $0.60 per diluted share, for the corresponding period in fiscal 2015. For the first six months of fiscal 2016, Hurco reported net income of $7,569,000, or $1.14 per diluted share, compared to $7,727,000, or $1.17 per diluted share, for the corresponding period in fiscal 2015.
HURC: 31.68 (-0.45)

Hurco Cos Up 21.7% Since SmarTrend Uptrend Call (HURC)
Comtex SmarTrend(R) - Thu May 05, 1:28PM CDT
SmarTrend identified an Uptrend for Hurco Cos (NASDAQ:HURC) on February 22nd, 2016 at $26.96. In approximately 2 months, Hurco Cos has returned 21.68% as of today's recent price of $32.80.
HURC: 31.68 (-0.45)

Hurco Cos Shares Up 22.8% Since SmarTrend's Buy Recommendation (HURC)
Comtex SmarTrend(R) - Tue Apr 19, 12:59PM CDT
SmarTrend identified an Uptrend for Hurco Cos (NASDAQ:HURC) on February 22nd, 2016 at $26.96. In approximately 2 months, Hurco Cos has returned 22.80% as of today's recent price of $33.10.
HURC: 31.68 (-0.45)

22.4% Return Seen to Date on SmarTrend Hurco Cos Call (HURC)
Comtex SmarTrend(R) - Fri Apr 01, 12:56AM CDT
SmarTrend identified an Uptrend for Hurco Cos (NASDAQ:HURC) on February 22nd, 2016 at $26.96. In approximately 1 month, Hurco Cos has returned 22.39% as of today's recent price of $32.99.
HURC: 31.68 (-0.45)

13.6% Return Seen to Date on SmarTrend Hurco Cos Call (HURC)
Comtex SmarTrend(R) - Tue Mar 08, 10:21AM CST
SmarTrend identified an Uptrend for Hurco Cos (NASDAQ:HURC) on February 22nd, 2016 at $26.96. In approximately 2 weeks, Hurco Cos has returned 13.56% as of today's recent price of $30.61.
HURC: 31.68 (-0.45)

Hurco Reports First Quarter Results for Fiscal 2016
GlobeNewswire - Fri Mar 04, 7:00AM CST
Hurco Companies, Inc. (Nasdaq:HURC) today reported results for the first fiscal quarter ended January 31, 2016. Hurco recorded net income of $3,895,000, or $0.58 per diluted share, for the first quarter of fiscal 2016 compared to net income of $3,766,000, or $0.57 per diluted share, for the corresponding period in fiscal 2015.
HURC: 31.68 (-0.45)

Hurco Reports Fourth Quarter and Full-Year Results for Fiscal 2015
GlobeNewswire - Fri Jan 08, 7:00AM CST
Hurco Companies, Inc. (Nasdaq:HURC) today reported results for the fourth fiscal quarter and fiscal year ended October 31, 2015. Hurco recorded net income of $4,804,000, or $0.72 per diluted share, for the fourth quarter of fiscal 2015 compared to net income of $4,863,000, or $0.74 per diluted share, for the corresponding period in fiscal 2014. For fiscal 2015, Hurco reported net income of $16,214,000, or $2.44 per diluted share, compared to $15,143,000, or $2.30 per diluted share, for fiscal 2014.
HURC: 31.68 (-0.45)

Downtrend Call Working As Hurco Cos Stock Falls 16.1% (HURC)
Comtex SmarTrend(R) - Thu Sep 24, 11:23AM CDT
SmarTrend identified a Downtrend for Hurco Cos (NASDAQ:HURC) on July 24th, 2015 at $32.20. In approximately 2 months, Hurco Cos has returned 16.10% as of today's recent price of $27.01.
HURC: 31.68 (-0.45)

Hurco Cos Has Returned 13.2% Since SmarTrend Recommendation (HURC)
Comtex SmarTrend(R) - Thu Sep 17, 10:03AM CDT
SmarTrend identified a Downtrend for Hurco Cos (NASDAQ:HURC) on July 24th, 2015 at $32.20. In approximately 2 months, Hurco Cos has returned 13.20% as of today's recent price of $27.95.
HURC: 31.68 (-0.45)

Hurco Announces Acquisition of Two Machine Tool Companies
GlobeNewswire - Wed Jul 15, 10:16AM CDT
Hurco Companies, Inc. (Nasdaq:HURC), a leader in the development and manufacture of machine tools with integrated control technologies for the worldwide metal cutting market, announced today that, through a wholly-owned subsidiary, it acquired substantially all of the assets of U.S.-based Milltronics Manufacturing Company, Inc. d/b/a Milltronics CNC Machines (Milltronics). Founded in 1973, Milltronics designs and manufactures CNC knee mills, toolroom bed mills, vertical machining centers, combination lathes, slant-bed lathes, horizontal machining centers, and bed mills.
HURC: 31.68 (-0.45)

Hurco Reports Second Quarter Results and Announces Quarterly Cash Dividend
GlobeNewswire - Fri Jun 05, 7:00AM CDT
Hurco Companies, Inc. (Nasdaq:HURC) today reported results for the second fiscal quarter and the first six months ended April 30, 2015. Hurco recorded net income of $3,961,000, or $0.60 per diluted share, for the second quarter of fiscal 2015 compared to net income of $3,536,000, or $0.54 per diluted share, for the corresponding period in fiscal 2014. For the first six months of fiscal 2015, Hurco reported net income of $7,727,000, or $1.17 per diluted share, compared to $5,905,000, or $0.90 per diluted share, for the corresponding period in fiscal 2014.
HURC: 31.68 (-0.45)

Shares of HURC Down 11.9% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Wed Mar 18, 11:46AM CDT
SmarTrend identified a Downtrend for Hurco Cos (NASDAQ:HURC) on February 11th, 2015 at $34.24. In approximately 1 month, Hurco Cos has returned 11.95% as of today's recent price of $30.15.
HURC: 31.68 (-0.45)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 15

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 19

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 20

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 14

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 19

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 24

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 24

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 18

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 19

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

LightBox CRE Activity Index Sees Positive Response to Rates

Updated Category News Views 67

Introduction to LightBox's Findings Recent insights from LightBox reveal significant shifts in the commercial real estate (CRE) sector, highlighting increased activity in response to recent economic changes. As a leading provider of CRE information and technology, LightBox's Monthly CRE Activity Index plays a crucial role in tracking the dynamics of the market....

Continue Reading
Alliance Pharma's Recent Trading Activity on the LSE Explored

Updated Category News Views 167

Understanding Alliance Pharma's Trading Activity Alliance Pharma plc, known for its strategic positioning in the pharmaceutical market, has made a significant impact through its recent trading activities. These transactions are crucial for understanding the company's current standing and future potential in the market. The firm operates under the stock ticker LSE:INVP,...

Continue Reading
Icon Energy Corp. Welcomes M/V Bravo and Secures Funding

Updated Category News Views 83

Icon Energy Corp. Welcomes M/V Bravo and Secures Financing Icon Energy Corp. (“Icon”) (Nasdaq: ICON) is thrilled to announce the arrival of its latest fleet member, the M/V Bravo, alongside significant financing aimed at facilitating future growth. This advanced Kamsarmax dry bulk carrier represents a key achievement in Icon's operational strategy, paving the way for...

Continue Reading
Coinbase Investor Alert: Class Action Lawsuit Filed Against Company

Updated Category News Views 403

Traders braced for turmoil as Coinbase Global, Inc. (NASDAQ: COIN) found itself entangled in a significant class action lawsuit back in 2024, brought forth by the reputable law firm Bronstein, Gewirtz & Grossman. This isn’t just another legal skirmish; it’s an alarm bell ringing loudly for investors who acquired Coinbase securities during the defined Class Period....

Continue Reading
Danny Go! Launches Exciting New Toy Line with Just Play

Updated Category News Views 447

Danny Go! Launches Exciting New Toy Line Three new active-play toys inspired by the beloved YouTube series, Danny Go!, are set to hit shelves just in time for the holiday season. This innovative collaboration between Danny Go! and Just Play, a prominent toy company, aims to engage children through play, song, and dance. Exciting Toy Debut at Walmart The launch of these...

Continue Reading